RESEARCH INTERESTS

• Clinical assessment of new or existing therapies for hypertension, myocardial ischemia, or congestive heart failure

• Research design

1. Stringer K.M., Lopez L.M.  “Management of Uncomplicated Myocardial Infarction.”  In: DiPiro J.T., Talbert R.L., Yee G.C., Matzge G.R., Wells B.G., Posey L.M., eds. Pharmacotherapy: A Pathophysiologic Approach, Fifth ed New York,N.Y.: Appleton and Lange, 251-272 (2002).
2. Lopez L.M.  “Low Molecular Weight Heparins are Essentially the Same for Prevention and Treatment of Venous Thromboembolism.”  Pharmacotherapy, 21(Suppl):56s–61s (2001).
3. Pepine C.J., Lopez L.M., Bell D.M., Handberg E.M., Marks R.G., McGorry S.  “Effects of Intermittent Transdermal-Nitroglycerin on Occurrence of Ischemia after Patch Removal: Results of the Transderm-nitro Intermittent Dosing Evaluation-II (TIDES-II).”  Journal of the American College of Cardiology, 30:955-961 (1997).
4. Mehta J.L., Lopez L.M., Chen L., Cox O.E.  “Alterations in Nitric Oxide Synthase Activity, Superoxide Anion Generation, and Platelet Aggregation in Systemic Hypertension, and Effects of Celiprolol.”  American Journal of Cardiology, 74:901-905 (1994).
5. Mehta J.L., Lopez L.M., Vlachakis N.D., Gradman A.H., Nash D.T., O'Connel M.T., Garland W.T., Pechering B.I.  “Double-Blind Evaluation of the Dose Response Relationship of Amodipine in Essential Hypertension.”  American Heart Journal, 125:1704-1710 (1993).